Numab Funding: $185M Raised, Series B (2020)

Numab is a Biotech company based in Zurich area, Switzerland. It has raised $185M in total funding. Latest round: Series B.

Numab funding overview

Numab is a Biotech company based in Zurich area, Switzerland. Numab has raised $185M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2020. The round record for Numab runs through 2020; nothing later has been disclosed. Investors on record include 3SBio/Sunshine Guojian, Mitsubishi UFJ Capital Co., Ltd., Eisai Co., Ltd.. 3 distinct backers are named across the disclosed rounds.

Numab at a glance

Total raised
$185M
Latest round
Series B
Latest round date
March 2020
Industry
Biotech
Headquarters
Zurich area, Switzerland
Notable investors
3SBio/Sunshine Guojian, Mitsubishi UFJ Capital Co., Ltd., Eisai Co., Ltd.

Frequently asked about Numab funding

How much has Numab raised?
Numab has raised $185M in total disclosed funding across the rounds on record.
Who has invested in Numab?
3SBio/Sunshine Guojian, Mitsubishi UFJ Capital Co., Ltd., Eisai Co., Ltd. are named among the investors backing Numab.
What was the latest Numab funding round?
The most recent disclosed round is a Series B, announced in March 2020.
Where is Numab based?
Numab is based in Zurich area, Switzerland.
What sector does Numab operate in?
Numab is tracked under Biotech from Zurich area, Switzerland, with $185M in disclosed funding.
When did Numab last raise?
The last disclosed Numab round closed in March 2020 at Series B.

Round data for Numab is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Zurich area and backer lists below.

Numab founders (1)

Companies related to Numab (18)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026